CD34 and acute myeloid leukemia: LSCs of AML are a subset of CD34-positive and CD38-negative cells, according to the current paradigm, and they may be recognized by a number of molecular markers.[66] Currently, it is widely accepted that LSCs are the cause of AML, making the elimination of LSCs crucial.